Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-22 M&A
PharmAla Biotech Holdings Inc. Enters into Definitive SPV Formation, Shareholder and License Agreement with Aluvaris Inc. and Diteba Inc. for APA-01 Development and Term Sheet with Jupiter Neurosciences, Inc. for Exclusive U.S. Rights to ALA-002
Material change report - English.pdf
Ownership 2026-05-21
Ryer, Lennie bought +$5k
Insider trading – 2026-05-21
1 insider · +$5k net
Transactions 2026-05-20 M&A
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
News release - English.pdf
Transactions 2026-05-13 Financing
Other material contracts - English.pdf
Transactions 2026-05-13 M&A
PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01
News release - English.pdf
Ownership 2026-04-30
Kazemzadeh, Farnoud · 10 - Acquisition or disposition in the public market
Insider trading – 2026-04-30
1 insider · $0 net
Transactions 2026-04-27 M&A
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
News release - English.pdf
Results 2026-04-21
PharmAla Issues Q2 Financial Statements and Grants Options
News release - English.pdf
Results 2026-04-21
Interim MD&A - English.pdf
Results 2026-04-21
Interim financial statements/report – English.pdf
News 2026-04-20
PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order
News release - English.pdf
News 2026-03-23
PharmAla Biotech's Cortexa Advances Commercialisation of MDMA Supply in Australia
News release - English.pdf
News 2026-03-03
PharmAla Biotech Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders
News release - English.pdf
News 2026-02-26
PharmAla Biotech Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
News release - English.pdf
News 2026-02-23
PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data
News release - English.pdf
News 2026-01-08
PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research
News release - English.pdf
Results 2025-12-24
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
News release - English.pdf
Results 2025-12-24 Financials
Interim financial statements/report – English.pdf
Results 2025-12-24 Financials
Interim MD&A - English.pdf
Results 2025-12-23 Financials
Annual MD&A - English.pdf
Results 2025-12-23 Financials
Audited annual financial statements – English.pdf
News 2025-12-15
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
News release - English.pdf
News 2025-12-10
PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules
News release - English.pdf
News 2025-11-10
Material change report - English.pdf
News 2025-11-03
News release - English.pdf
News 2025-10-31
Auditors' consent letter.pdf
Transactions 2025-10-30 Financing
Undertaking to file documents and material contracts.pdf
Transactions 2025-10-30 Financing
Final short form prospectus – English.pdf
News 2025-10-09
Material change report - English.pdf
News 2025-10-08
News release - English.pdf
News 2025-10-02
News release - English.pdf
News 2025-09-25
News release - English.pdf
News 2025-09-19
News release - English.pdf
News 2025-09-18
Decision Document (Amendment to Preliminary).pdf
Transactions 2025-09-18
Amendment to (or amended) preliminary short form prospectus – English.pdf
News 2025-09-12
Material change report - English.pdf
News 2025-09-08
News release - English.pdf
News 2025-09-03
News release - English.pdf
News 2025-08-07
News release - English.pdf
News 2025-07-25
News release - English.pdf
Results 2025-07-25 Financials
Interim MD&A - English.pdf
Results 2025-07-25 Financials
Interim financial statements/report – English.pdf
News 2025-06-30
Material change report - English.pdf
News 2025-06-20
News release - English.pdf
News 2025-06-20
Decision Document (Preliminary).pdf
News 2025-06-20
Qualification certificate.pdf
Transactions 2025-06-20
Preliminary short form prospectus – English.pdf
News 2025-06-03
News release - English.pdf
News 2025-06-03
News release - English.pdf
News 2025-06-03
News release - English.pdf
News 2025-06-03
News release - English.pdf